Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy

EMBO Journal

Volumn 21, Issue 16, 2002, Pages 4307-4316

  Enge, Maria ^a   Bjarnegård, Mattias ^a   Gerhardt, Holger ^a   Gustafsson, Erika ^a   Kalén, Mattias ^a   Asker, Noomi ^a   Hammes, Hans Peter ^a   Shani, Moshe ^a   Fässler, Reinhardt ^a   Betsholtz, Christer ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

CrexP system; Diabetes; Pericytes; Platelet derived growth factor; Retinopathy

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; GENE DELETION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN; CAPILLARIES; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; GENE DELETION; GENE TARGETING; MICE; MICE, TRANSGENIC; PERICYTES; PROTO-ONCOGENE PROTEINS C-SIS; RETINA; RETINAL VESSELS;

ANIMALIA;

EID: 18544366585     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf418     Document Type: Article

References (33)

1. Analysis of mural cell recruitment to tumor vessels
2. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
3. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
4. Islet transplantation in experimental diabetes of the rat. XII. Effect on diabetic retinopathy. Morphological findings and morphometrical evaluation
5. Aldose reductase in retinal mural cells
6. Retinal vascular patterns. IV. Diabetic retinopathy
7. Chimaeric analysis reveals role of PDGF receptors in all muscle lineages
8. Pathogenesis of diabetic retinopathy
9. Isolation, characterization and long-term culture of human myometrial microvascular endothelial cells
10. Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice
11. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
12. Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
13. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis
14. The Wisconsin epidemiologic study of diabetic retinopathy. II: Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
15. The Wisconsin epidemiologic study of diabetic retinopathy. III: Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
16. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions
17. Mice deficient for PDGF B show renal, cardiovascular and hematological abnormalities
18. Defective angiogenesis in mice lacking endoglin
19. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
20. Paracrine PDGF-B/PDGF-Rβ signaling controls mesangial cell development in kidney glomeruli
21. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
22. Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis
23. PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta
24. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis
25. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth
26. The pericyte-A review
27. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice
28. Arteriolar and venolar patterning in retinas of mice selectively expressing VEGF isoforms
29. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic development
30. Retention of PDGFR-β function in mice in the absence of phosphatidylinositol 3′-kinase and phospholipase C signaling pathways
31. A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells
32. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5